Yieldmax Mrna Option Income Strategy ETF (MRNY) closed at $44.50 on November 6, 2026, up 3.2% from the previous close, on volume of 594,736 shares (30-day average 351,961).
Data as of November 6, 2026.
6-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
No press releases found.
YieldMax MRNA Option Income Strategy ETF announces weekly distribution of $0.7297
Seeking Alpha News (Wed, 4-Nov 10:21 AM ET)
The Fund's primary investment objective is to seek current income. The Fund's secondary investment objective is to seek exposure to the share price of the common stock of Moderna, Inc. ("MRNA" or "Underlying Security"), subject to a limit on potential investment gains. The Fund is an actively managed exchange-traded fund ("ETF") that seeks current income while providing indirect exposure to the share price (i.e., the price returns) of the common stock of Moderna, Inc. ("MRNA" or the "Underlying Security"), subject to a limit on potential investment gains. The Fund will employ its investment strategy as it relates to MRNA regardless of whether there are periods of adverse market, economic, or other conditions and will take temporary defensive positions during such periods. As further described below, the Fund uses either a synthetic covered call strategy or a synthetic covered call spread strategy to provide income and indirect exposure to the share price returns of MRNA, subject to a limit on potential investment gains as a result of the nature of the options strategy it employs. That is, the Fund not only seeks to generate income from its options investments but also aims to derive gains when the value of MRNA increases.
Yieldmax Mrna Option Income Strategy ETF trades on the ARCA stock market under the symbol MRNY.
As of November 6, 2026, MRNY stock price climbed to $44.50 with 594,736 million shares trading.
MRNY has a beta of 0.18, meaning it tends to be less sensitive to market movements. MRNY has a correlation of 0.00 to the broad based SPY ETF.
MRNY has a market cap of $263.88 million. This is considered a Small Cap stock.
In the last 3 years, MRNY traded as high as $260.00 and as low as $13.60.
MRNY has outperformed the market in the last year with a price return of +322.8% while the SPY ETF gained +10.8%. MRNY has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +271.6% and +19.8%, respectively, while the SPY returned -4.1% and -3.2%, respectively.
MRNY support price is $40.73 and resistance is $45.53 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MRNY shares will trade within this expected range on the day.
